Cátedra María José Faus de Atención Farmacéutica

Multimodal Chronic Pain Therapy for Adults Via Smartphones: A Randomized Controlled Clinical Trial

Morcillo-Muñoz Y, Sanchez-Guarnido AJ, Calzón-Fernández S, Baena-Parejo MI

J Med Internet Res . 2022 Mar 31. doi: 10.2196/36114. Online ahead of print

Indicio de calidad: 5/30 (MEDICAL INFORMATICS). Fi: 5.428, T1, Q1

Impacto clínico real de interacciones medicamentosas de los fármacos inmunosupresores en pacientes trasplantados

Gago-Sánchez AI, Font P, Cárdenas M, Aumente MD, Del Prado JR, Calleja MÁ

Pharmacol Res Perspect. 2021 Dec;9(6):e00892. doi: 10.1002/prp2.892.

Indicio de calidad: 175/276 (Pharmacology & Pharmacy). Fi: 2.794, T2, Q3

Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial

Torres-Robles A, Benrimoj SI, Gastelurrutia MA, Martinez-Martinez F, Peiro T, Perez-Escamilla B, Rogers K, Valverde-Merino I, Varas-Doval R, Garcia-Cardenas V.

BMJ Qual Saf 2021; 0:1–11. doi:10.1136/bmjqs-2020-011671

Indicio de calidad: 3/107 (Health Care Sciences & Services). Fi: 7.035, T1, Q1

Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer

Pineda Lancheros, L, Pérez Ramírez C, Sánchez Martín A, Gálvez Navas JM, Martínez Martínez F, Ramírez Tortosa MC, Jiménez Morales A.

Nutrients 2021. 13, no. 11: 3783. https://doi.org/10.3390/nu13113783

Indicio de calidad: 17/88 (Nutrition & Dietetics). Fi: 5.719, T1, Q1

Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis

Márquez Pete N , María Del Maldonado Montoro MM , Pérez Ramírez C , Fernando Martínez Martínez F , Juan Enrique Martínez de la Plata JE, Daddaoua A, Jiménez Morales A

Journal of Personalized Medicine . 2021 Jun 18;11(6):573. doi: 10.3390/jpm11060573.

Indicio de calidad: 24/165 (Medine General & Internal). Fi: 4945, T1, Q1

Influence of Genetic Polymorphisms on Clinical Outcomes of GlatiramerAcetate in Multiple Sclerosis Patients

Zarzuelo Romero MJ, Pérez Ramírez C, Cura Y, Carrasco Campos MI, Marangoni LM, Ramírez Tortosa MC, Jiménez Morales A.

Journal of Personalized Medicine

Indicio de calidad: 15/108 (Health Care Sciences & Services). Fi: 4945, T1, Q1

Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis

Zarzuelo Romero MJ, Pérez Ramírez C, Carrasco Campos MI, Sánchez Martín A, Calleja Hernández MA, Ramírez Tortosa MC, Jiménez Morales A.

Journal of Personalized Medicine; 2021,

Indicio de calidad: 15/108 (Medine General & Internal). Fi: 4.945, T1, Q1

Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis

Membrive Jiménez C, Pérez Ramírez C, Sánchez Martín A, Vieira Maroun S, Arias Santiago SA, Ramírez Tortosa MDC, Jiménez Morales A.

J Pers Med. 2021 Apr 12;11(4):293. doi: 10.3390/jpm11040293. PMID: 33921427 Free PMC article. Review.

Indicio de calidad: 10/102 (Health Care Sciences & Services). Fi: 4.433, T1, Q1

Hospitalization budget impact during the COVID-19 pandemic in Spain

Carrera-Hueso FJ, Álvarez-Arroyo L , Poquet-Jornet JE , Vázquez-Ferreiro P , Martínez-Gonzalbez R, El-Qutob D, Ramón-Barrios MA, Martínez-Martínez F, Poveda-Andrés JL and Crespo-Palomo C

Health Economics Review (2021) 11:43 https://doi.org/10.1186/s13561-021-00340-0

Indicio de calidad: 210/557 (Economics). Fi: FI: 2.306, T1, Q2

Integration of community pharmacy in primary health care: The challenge

Piquer-Martinez C, Urionagüena A, Benrimoj SI, Calvo B, Martinez-Martinez F, Fernandez-Llimos F, Garcia-Cardenas V, Gastelurrutia MA

Research in Social and Administrative Pharmacy, https://doi.org/10.1016/j.sapharm.2021.12.005

Indicio de calidad: 46/176 (Public, Environmental & Occupational Health). Fi: 3.336, T1, Q2

Validation of a spanish version of the ‘Unité Rhumatologique Des Affections De La Main’ (URAM) scale

Gómez-Herrero D, Carrera-Hueso FJ , Sanjuan-Cerveró R , Montaner-Alonso D , Aguilella-Fernandez L , Vazquez-Ferreiro P , Poquet-Jornet JE, García-Jiménez E

Journal of Plastic Reconstructive and Aesthetic Surgery . 2021 Jul;74(7):1621-1628. doi: 10.1016/j.bjps.2020.11.024. Epub 2020 Dec 5.

Indicio de calidad: 90/212 (Surgery). Fi: 2.740, T1, Q2

A cost utility analysis alongside a cluster-randomised trial evaluating a minor ailment service compared to usual care in community pharmacy

 Amador-Fernández N, Benrimoj SI, García-Mochon L, García Cárdenas V, Dineen-Griffin S, Gastelurrutia MA, Gómez Martínezs JC, Colomer-Molina V, Martínez Martínez F

BMC health services research vol. 21,1 1253. 20 Nov. 2021, doi:10.1186/s12913-021-07188-4.

Indicio de calidad: 55/107 (Health care sciences & services). Fi: 2.655, , T1, Q3

Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis

Cancela Díez B, Pérez-Ramírez C, Maldonado-Montoro MDM, Carrasco-Campos MI, Sánchez Martín A, Pineda Lancheros LE, Martínez-Martínez F, Calleja-Hernández MÁ, Ramírez-Tortosa MC, Jiménez-Morales A.

Pharmacogenet Genomics. 1;31(2):40-47. doi: 10.1097/FPC.0000000000000420.

Indicio de calidad: 116/271 (Pharmacology & Pharmacy). Fi: 2.940, T2, Q2

Cost–Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community

Valverde-Merino MI, Martinez-Martinez F, Garcia-Mochon L, Benrimoj SI, Malet-Larrea A, Perez-Escamilla B, Zarzuelo MJ, Torres-Robles A, Gastelurrutia MA, Varas-Doval R, Peiro Zorrilla T, Garcia-Cardenas V.

Patient Prefer Adherence. 2021;15:2363-2376. https://doi.org/10.2147/PPA.S330371

Indicio de calidad: 63/167 (Medine General & Internal). Fi: 2.711, T2, Q2

Impact of a risk-sharing agreement in rheumatoid arthritis in Spain.

García-Collado CG, Martínez-de-la-Plata JE, Montoro MDMM, Morales AJ, Hernández MÁC, Martínez FM

Health Policy . 2021 Mar;125(3):335-340. doi: 10.1016/j.healthpol.2020.11.009. Epub 2020 Nov 16.

Indicio de calidad: 33/87 (Health Care Sciences & Services). Fi: 2.212, T2, Q2

Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies.

Varas-Doval R, Saéz-Benito L, Gastelurrutia M. A, Benrimoj S. I, Garcia-Cardenas V, and Martinez-Martínez F.

BMC Health Services Research (2021) 21:156

Indicio de calidad: 57/102 (Health Policy & Services). Fi: 1.987, T2, Q3

Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment

Cárdaba-García, María, Calleja Hernández MA

Libyan journal of medicine vol. 16,1 (2021): 1949797. doi:10.1080/19932820.2021.1949797

Indicio de calidad: 107/167 (Medine General & Internal). Fi: 1.657, T2, Q3

Multimodal Interventions to Improve the Management of Chronic Non-Malignant Pain in Primary Care Using Participatory Research

Morcillo-Muñoz Y, Holgado Jiménez Castellano, Díaz Exposito FJ, Sanchez-Guarnido AJ, Gimenez Alcantara M, Baena-Parejo MI

Clinics and Practice. Aug 26;11(3):561-581. doi: 10.3390/clinpract11030072.

Indicio de calidad: 181/315 (Medicine, General & Internal). Fi: 0.23, T3, Q3

Adaptation of practical classes of clinical subjects in the COVID-19 era

Zarzuelo MJ, Valverde-Merino MI, Sanchez-Perez de Lara L, Martinez-Martinez F

Brazilian Journal of Pharmaceutical Sciences

Indicio de calidad: 251/275 (Pharmacology & Pharmacy). Fi: 1.321, T3, Q4

Intervention model for detection, prevention and control of COVID-19 in community pharmacy

Cortes-Fernandez E, Zarzuelo MJ, Valverde-Merino MI, Martinez-Martinez F

Brazilian Journal of Pharmaceutical Sciences

Indicio de calidad: 251/275 (Pharmacology & Pharmacy). Fi: 1.321, T3, Q4

Results Of Development And Application Of An Objective Structured Clinical Examination: A Pioneering Experience In Pharmaceutical Care.

Zarzuelo MJ, Valverde-Merino MI, Fernandez-Rodriguez M, Amador-Fernandez N, Uribe-Sanchez A, Gomez-Guzman M, Martinez-Martinez F.

Indian Journal Of Pharmaceutical Education And Research. 2021.

Indicio de calidad: 266/275 (Pharmacology & Pharmacy). Fi: 0.686, T3, Q4

Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta

Martínez-Aguilar L, Pérez-Ramírez C, Maldonado-Montoro MDM, Carrasco-Campos MI, Membrive-Jiménez C, Martínez-Martínez F, García-Collado C, Calleja-Hernández MÁ, Ramírez-Tortosa MC, Jiménez-Morales A

Mutat Res/Reviews in Mutation Research. Jul-Sep 2020;785:108322. doi: 10.1016/j.mrrev.2020.108322. Epub 2020 Jul 7.

Indicio de calidad: 20/178 (Genetic Heredity). Fi: 5.803, T1, Q1

Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Efectiveness of Abatacept in Patients with Rheumatoid Arthritis

Marquez Pete N, Maldonado Montoro MM, Pérez Ramírez C, Sánchez Martín A, Martínez de la Plata JE, Martínez Martínez F, Caliz Caliz R, Daddaoua A, Ramírez Tortosa MC, Jiménez Morales A

J Pers Med . 2020 Nov 11;10(4):220. doi: 10.3390/jpm10040220.

Indicio de calidad: 24/165 (Medine General & Internal). Fi: 4.433, T1, Q1

Collaborative health service planning: a stakeholder analysis with social network analysis to develop a community pharmacy service

Franco-Trigo L, Marqués-Sánchez P, Tudball J, Benrimoj SI, Martínez-Martínez F, Sabater-Hernández D.

Res Social Adm Pharm. 2020 Feb;16(2):216-229. doi: 10.1016/j.sapharm.2019.05.008. Epub 2019 May 21.

Indicio de calidad: 33/171 (Public, Environmental & Occupational Health). Fi: 2.844, T1, Q1

Using network analysis to explore factors moderating the implementation of a medication review service in community pharmacy.

Pérez-Escamillla B, Benrimoj SI, Martínez-Martínez F, Gastelurrutia MÁ, Varas-Doval R, Musial-Gabrys K, Garcia-Cardenas V.

Res Social Adm Pharm . 2020 Dec 19;S1551-7411(20)31212-2. doi: 10.1016/j.sapharm.2020.12.007. Online ahead of print.

Indicio de calidad: 33/71 (Public, Environmental & Occupational Health). Fi: 2.844, T1, Q1

Association of genetic polymorphisms on methotrexate toxicity in patients with rheumatoid arthritis.

Zarzuelo Romero MJ, Martínez Martínez F, Maldonado Montoro MM, Pérez Ramírez C, Calleja Hernández MA, Márquez Pete N, Sánchez Martín A, Jiménez Morales A, Ramírez Tortosa MC.

Archives of Medical Science. 2020.

Indicio de calidad: 51/169 (Medine General & Internal). Fi: 3.318, T1, Q2

Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: translating evidence into practice.

Varas-Doval R, Gastelurrutia MA , Benrimoj SI, Zarzuelo MJ, Garcia-Cardenas V, Perez-Escamilla B, Martinez-Martinez F.

BMJ Open . 2020 Sep 29;10(9):e036669. doi: 10.1136/bmjopen-2019-036669.

Indicio de calidad: 52/165 (Medine General & Internal). Fi: 2.496, T1, Q2

Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program.

Sadyrbaeva-Dolgova S, Aznarte-Padial P, Jimenez-Morales A, Expósito-Ruiz M, Calleja-Hernández MÁ, Hidalgo-Tenorio C.

J Infect Public Health. 2020 Apr;13(4):558-563. doi: 10.1016/j.jiph.2019.09.014. Epub 2019 Nov 1. PMID: 31685404 Free article.

Indicio de calidad: 73/193 (Public, Environmental & Occupational Health). Fi: 2.447, T1, Q2

Validation of a spanish versión of the “Unité Rhumatologiqué de Affections de la Main” (URAM) scale.

Gómez-Herrero D, Carrera-Hueso FJ, Sanjuán-Cerveró R, Montaner-Alonso D, Aguilella-Fernández L, Vazquez-Ferreiro P, Poquet-Jornet JE, García-Jiménez E.

Journal of Plastic, Reconstructive & Aesthetic Surgery

Indicio de calidad: 72/210 (Surgery). Fi: 2.390, T1, Q2

Stakeholder analysis in health innovation planning processes: Asystematic scoping review

Franco-Trigo l, Fernandez-Llimos F, Martínez-Martínez F, Benrimoja SI, Sabater-Hernández D

Health Policy . 2020 Oct;124(10):1083-1099. doi: 10.1016/j.healthpol.2020.06.012. Epub 2020 Jun 30.

Indicio de calidad: 33/87 (Health Care Sciences & Services). Fi: 2.212, T2, Q2

Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties

Pareja-Martínez E, Esquivel-Prados E, Martínez- Martínez F, García-Corpas JP

Int J Clin Pharm . 2020 Apr;42(2):355-365. doi: 10.1007/s11096-020-00981-x. Epub 2020 Feb 5.

Indicio de calidad: 228/271 (Pharmacology and Pharmacy). Fi: 1.616, T3, Q4

Training in Professional Pharmacy Services through Educational Videos.

Zarzuelo Maria Jose, Valverde-Merino Maria-Isabel, Fernandez-Rodriguez Maria, Amador-Fernandez Noelia, Martinez-Martinez Fernando.

Indian Journal of Pharmaceutical Education and Research, 2020.

Indicio de calidad: 266/275 (Pharmacology & Pharmacy). Fi: 0.686, T3, Q4

Acute coronary syndrome and recurrent colitis as immune-related adverse events in a lung cancer patient.

Cancela-Díez B, Gómez-De Rueda F, Antolinos Pérez MJ, Jiménez-Morales A, López-Hidalgo JL.

J Oncol Pharm Pract. 2020 Jan;26(1):252-255. doi: 10.1177/1078155219865596. Epub 2019 Aug 5. PMID: 31382863

Indicio de calidad: 213/244 (Oncology). Fi: 1.850, T4, Q4

Hydroxytyrosol, antioxidant of extra virgin olive oil, modifies the levels of TIMP-1 in plasma of women with breast cancer.

Ramirez-Tortosa C, Sanchez A, Perez-Ramirez C, Quiles JL, Robles-Almazan M, Pulido-Moran M, Sanchez-Rovira M, Ramirez-Tortosa MC

Antioxidants, 2019, En prensa

Indicio de calidad: 63/298 (Biochemestry & Molecular Biology). Fi: 4.520, T1, Q1

A stakeholder visioning exercise to enhance chronic care and the integration of community pharmacy services.

Franco-Trigo L, Tudball J, Fam D, Benrimoj SI, Sabater-Hernández D.

Res Social Adm Pharm, 2019, Jan;15(1):31-44. doi: 10.1016/j.sapharm.2018.02.007. Epub 2018 Feb 21

Indicio de calidad: 37/157 (Public, Enviromental, Ocupacional Health). Fi: 2.322, T1, Q1

FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis

Jiménez Morales A, Maldonado-Montoro M, Martínez de la Plata JE, Pérez Ramírez C, Daddaoua A, Alarcón Payer C, Expósito Ruiz M, García Collado C.

J Clin Pharmacol. 2019 Apr;59(4):517-531. doi: 10.1002/jcph.1341. Epub 2018 Nov 20.

Indicio de calidad: 110/267 (Pharmacology and Pharmacy). Fi: 2.915, T1, Q2

A comparative analysis of the pharmacovigilance systems of Brazil, Spain, the European Union and the United States based on the information provided by their regulatory agency websites.

Leal MM, Sanz MM, Ferrando JRC, Martinez-Martinez F.

Daru, 2019, Feb 18. doi: 10.1007/s40199-019-00249-4

Indicio de calidad: 118/261 (Pharmacology & Pharmacy). Fi: 2.667, T2, Q2

Cross sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study.

Rodríguez-Fortúnez P, Franch-Nadal J, Fornos-Pérez JA, Martínez Martínez F et al.

BMJ Open, 2019, 9:e028467. doi:10.1136/ bmjopen-2018-02846

Indicio de calidad: 50/160 (Medicine, General & Internal). Fi: 2.376, T2, Q2

A Global Comparison of Internationalization Support Characteristics Available on College of Pharmacy Websites.

Nunes-da-Cunha I, Martinez Martinez F, Fernandez-Llimos F.

American Journal of Pharmaceutical Education, 2019, 83 (3) Article 6592

Indicio de calidad: 22/41 (Education, Scientific Disciplines). Fi: 1.495, T2, Q3

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model.

Nogueras A, Chinchilla Fernández MI, Martínez F, Faus MJ, Martínez Sesmero JM, Poveda Andrés JL, Calleja MÁ

Eur J Hosp Pharm Sci Pract, 2019, Jul; 26(4):242-243. doi: 10.1136/ejhpharm-2019-001905. Epub 2019 Jul 4

Indicio de calidad: 251/267 (Pharmacology & Pharmacy). Fi: 0.717, T4, Q4

Methodological quality assessment of network meta-analysis of drug interventions: implications from a systematic review.

Tonin FS, Borba HH, Leonart LP, Mendes AM, Steimbach LM, Pontarolo R, Fernandez-Llimos F.

Int J Epidemiol, 201,8 Sep 12. doi: 10.1093/ije/dyy197. [Epub ahead of print]

Indicio de calidad: 5/181 (Public, Enviromental, Ocupacional Health). Fi: 8.360, T1, Q1

Comparison of interventions to improve long-term medication adherence across different clinical conditions: a systematic review with network meta-analysis.

Torres-Robles AJ, Wiecek E, Tonin FS, Benrimoj SI, Fernandez-Llimos F, Garcia-Cardenas V.

Frontiers in Pharmacology, 2018, 24;9:1454

Indicio de calidad: 48/261 (Pharmacology & Pharmacy). Fi: 3.831, T1, Q1

Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Valdivia-Bautista J, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacogenomics Journal, 2018, doi 10.1038/s41397-018-0014-8

Indicio de calidad: 50/261 (Pharmacology & Pharmacy). Fi: 3.812, T1, Q1

An innovative and comprehensive technique to evaluate different measuresof medication adherence: The network meta-analysis.

Tonin FS, Wiecek E, Torres-Robles A, Pontarolo R, Benrimoj SI, Fernandez-Llimos F, & Garcia-Cardenas V.

Research in Social & Administrative Pharmacy, 2018, pii: S1551-7411(18)30407-8

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). Fi: 2.322, T1, Q1

A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level.

Hossain LN, Tudball J, Franco-Trigo L, Durks D, Benrimoj SI, & Sabater-Hernández, D.

Research in Social & Administrative Pharmacy, 2018, 14(8):765-775

Indicio de calidad: 37/157 (Pharmacology & Pharmacy). Fi: 2.322, T1, Q1

A review of international pharmacy-based minor ailment services and proposed service design model.

Aly M, Garcia-Cardenas V, Williams KA, Benrimoj, SI.

Research in Social & Administrative Pharmacy, 2018, 14 (11):989-998

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). Fi: 2.322, T1, Q1

A qualitative study of stakeholder views and experiences of minor aliment services in the United Kingdom

Aly M, García-Cárdenas V, Williams KA, Benrimoj SI.

Research in Social & Administrative Pharmacy, 2018, pii: S1551-7411(18)30221-3

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). Fi: 2.322, T1, Q1

Defining a set of standar dised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project.

Blade J, Calleja MÁ, Lahuerta JJ, Poveda JL, de Paz HD, Lizán L.

BMJ Open, 2018, Feb 22; 8(2):e018850. doi: 10.1136/bmjopen-2017-018850

Indicio de calidad: 43/155 (Medicine, General & Internal). Fi: 2.413, T1, Q2

Effects of Virgin Olive Oils Differing in Their Bioactive Compound Contents on Metabolic Syndrome and Endothelial Functional Risk Biomarkers in Healthy Adults: A Randomized Double-Blind Controlled Trial.

Sanchez-Rodriguez E, Lima-Cabello E, Biel-Glesson S, Fernandez-Navarro JR, Calleja MA, Roca M, Espejo-Calvo JA, Gil-Extremera B, Soria-Florido M, de la Torre R, Fito M, Covas MI, Alche JD, Martinez de Victoria E, Gil A, Mesa MD.

Nutrients, 2018, May 16; 10(5). pii: E626. doi: 10.3390/nu10050626

Indicio de calidad: 18/83 (Nutrition & Dietetics). Fi: 4.196, T2, Q1

Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with in flammatory bowel disease.

Guerra Veloz MF, Argüelles-Arias F, Castro Laria L, Maldonado Pérez B, Benítez Roldan A, Perea Amarillo R, Merino Bohórquez V, Calleja MA, Caunedo Álvarez Á, Vilches Arenas Á.

World J Gastroenterol, 2018, Dec 14; 24(46):5288-5296

Indicio de calidad: 35/80 (Gastroenterology & Hepatology). Fi: 3.300, T2, Q2

Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observacional longitudinal studies.

Leonart LP, Tonin FS, Ferreira VL, Fernandez-Llimos F, Pontarolo R.

Endocrine, 2018, https://doiorg/10.1007/s12020-018-1729-7.

Indicio de calidad: 63/174 (Endocrinology & Metabolism). Fi: 3.179, T2, Q2

Economic impact of medication non-adherence by disease groups: a systematic review.

Cutler, R. L.,Fernandez-Llimos, F., Frommer, M., Benrimoj, S. I.& Garcia-Cardenas, V.

BMJ open, 2018, Jan 21;8(1):e016982.doi:10.1016/j.sapharm.2017.12.004

Indicio de calidad: 50/160 (Medicine, General & Internal). Fi: 2.376, T2, Q2

Burnout en el personal de un Hospital de Crónicos.

Merino-Plaza MJ, Carrera-Hueso FJ, Arribas-Boscá N, Martínez-Asensi A, Trull-Mararavilla E, Fikri-Benbrahim N.

Revista Saude Publica, 2018, https://doi.org/10.11606/S1518-8787.2018052000242

Indicio de calidad: 120/176 (Public health, environmental & occupational health). Fi: 1.353, T2, Q2

Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.

Garrido P, Aldaz A, Vera R, Calleja MA, de Álava E, Martín M, Matías-Guiu X, Palacios J.

Clin Transl Oncol, 2018, Apr; 20(4):443-447. doi: 10.1007/s12094-017-1740-0. Epub 2017 Aug 31

Indicio de calidad: 156/223 (Oncology). Fi: 2.392, T2, Q3

A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation.

Sabater-Hernández D, Tudball J, Ferguson C, Franco-Trigo L, Hossain LN, Benrimoj SI.

BMC Health Serv Res, 2018, Feb 27; 18(1):145.

Indicio de calidad: 53/94 (Health Care Sciences & Services). Fi: 1.843, T2, Q3

Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Delgado JR, Calleja-Hernández MA, Faus-Dáder MJ

Pathology Res Practice, 2018, 214: 44-52

Indicio de calidad: 55/79 (Pathology). Fi: 1.466, T3, Q3

Characterization of pharmacists’ interventions on asthma management: a systematic review.

Crespo-Gonzalez C. Fernandez-Llimos F, Rotta I, Correr CJ, Benrimoj SI, & Garcia-Cardenas V.

Journal of the American Pharmacists Association, 2018, Mar - Apr;58(2):210-219

Indicio de calidad: 209/261 (Pharmacology & Pharmacy). Fi: 1.508, T3, Q4

Pharmacists in general practice: a focus on drug‑related problems.

Benson H, Lucas C, Kmet W, Benrimoj SI, & Williams KA.

International Journal of Clinical Pharmacy, 2018, Jun;40(3):566-572.

Indicio de calidad: 209/261 (Pharmacology & Pharmacy). Fi: 1.508 , T3, Q4

A model for the financial assessment of professional services in community pharmacy: a systematic review.

Zeater S, Benrimoj, SI, Fernandez-Llimos F, & Garcia-Cardenas V.

Journal of the American Pharmacists Association, 2018, [Epub ahead of print]doi: 10.1016/j.japh.2018.04.029

Indicio de calidad: 223/261 (Pharmacology & Pharmacy). Fi: 1.315, T3, Q4

Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer

Pérez-Ramírez C, Cañadas-Garre M, Molina-Vila MA, Robles AI, Faus-Dáder MJ, Calleja-Hernández MA.

Mutation Res Reviews in Mutation Res, 2017, 771: 32-58

Indicio de calidad: 26/171 (Genetic & Hereditary). Fi: 5.205, T1, Q1

Intraocular lens dislocation in pseudo exfoliation: a systematic review and meta-analysis.

Vazquez-Ferreiro P, Carrera-Hueso FJ, Fikri-Benbrahim N, Barreiro-Rodriguez L, Diaz-Rey M, Ramon Barrios MA.

Acta Ophthalmol, 2017; 95(3): e164-169

Indicio de calidad: 12/59 (Opthalmology). Fi: 3.324, T1, Q1

Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients.

Malet-Larrea A, Goyenechea E, Gastelurrutia MA, Calvo B, García-Cárdenas V, Cabases JM, Noain A, Martínez-Martínez F, Sabater-Hernández D, Benrimoj SI.

Eur J Health Econ, 2017, Dec; 18(9):1069-1078

Indicio de calidad: 51/353 (Economics). Fi: 2.601, T1, Q1

The complexity of implementation factors in professional pharmacy services.

Garcia-Cardenas V, Pérez-Escamilla B, Fernandez-Llimos F, & Benrimoj SI.

Research in Social & Administrative Pharmacy , 2017, May 29. pii: S1551-7411(17)30501-6.doi: 10.1016/j.sapharm.2017.05.016

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). Fi: 2.322, T1, Q1

Testing evidence routine practice: Using an implementation framework to embed a clinically proven asthma service in Australian community pharmacy.

Fuller JM, Saini, B, Bosnic-Anticevich, S, Garcia-Cardenas V, Benrimoj SI, & Armour C.

Research in Social & Administrative Pharmacy, 2017,13(5), 989-996

Indicio de calidad: 37/157 (Public Health, Environmental & Occupational Health). Fi: 2.322, T1, Q1

The next phase in professional services research: From implementation to sustainability.

Crespo-Gonzalez C, Garcia-Cardenas V, & Benrimoj SI.

Research in Social & Administrative Pharmacy, 2017, 13(5), 896-901

Indicio de calidad: 37/157 (Public, Enviromental, Ocupacional Health). Fi: 2.322, T1, Q1

Evaluation of the implementation process and outcomes of a professional pharmacy service in community pharmacy setting. A case report.

Garcia-Cardenas V, Benrimoj SI, Castrillon Ocampo C, Goyenechea E, Martinez-Martinez F, & Gastelurrutia Garralda MA.

Research in Social & Administrative Pharmacy, 2017, 13(3), 614-627.

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). Fi: 2.322, T1, Q1

Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.

Franco-Trigo L, Hossain LN, Durks D, Fam D, Inglis S., Benrimoj SI, & Sabater-Hernández D.

Research in Social & Administrative Pharmacy, 2017, 13(3), 539-552

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). Fi: 2.322, T1, Q1

Patients’ expectations of the role of the community pharmacist: Development and testing of a conceptual model.

Sabater-Galindo M, Ruiz de Maya S, Benrimoj SI, Gastelurrutia Garralda MA, Martínez-Martínez F, & Sabater-Hernández D.

Research in Social & Administrative Pharmacy, 2017, 13(2), 313-320.

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). Fi: 2.322, T1, Q1

Adherence of psychopharmacological prescriptions to clinical practice guidelines in patients with eating behavior disorders.

Alañón Pardo MM, Ferrit Martín M, Calleja Hernández MA, Morillas Márquez F.

Eur J Clin Pharmacol, 2017, 73: 1305-1313

Indicio de calidad: 117/261 (Pharmacology & Pharmacy). Fi: 2.679, T1, Q2

Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.

Hossain LN, Fernandez-Llimos F, Luckett T, Moullin JC, Durks D, Franco-Trigo L, Benrimoj SI, Sabater-Hernández D.

BMJ Open, 2017, Sep 5;7(9):e015471

Indicio de calidad: 43/154 (Medicine, General & Internal). Fi: 2.413, T1, Q2

Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service.

Puig L, Notario J, Jiménez-Morales A, Moreno-Ramírez D, López-Ferrer A, Gozalbo I, Prades M, Lizán L, Blanch C.

J Dermatolog Treat. 2017 Nov;28(7):623-630. doi: 10.1080/09546634.2017.1364687. Epub 2017 Oct 5. PMID: 28784002

Indicio de calidad: 25/64 (Dermatology). Fi: 2.144, T1, Q2

Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy.

Ríos-Tamayo R, Martín-García A, Alarcón-Payer C, Sánchez-Rodríguez D, de la Guardia AMDVD, García Collado CG, Jiménez Morales A, Jurado Chacón M, Cabeza Barrera J.

Drug Des Devel Ther.

Indicio de calidad: 99/271 (Pharmacology and Pharmacy). Fi: 3.216, T2, Q2

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Molina MA, Robles AI, Villar E, Delgado JR, Faus-Dáder MJ, Calleja-Hernández MA.

Surg Oncol, 2017, 26(3): 278-285

Indicio de calidad: 60/200 (Surgery). Fi: 2.558, T2, Q2

Cytokine single-nucleotide polymorphisms and risk of non-small cell lung cancer.

Pérez-Ramírez C, Alnatsha A, Cañadas-Garre M, Villar E, Valdivia-Bautista J, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacogenet Genomics, 2017; 27(12): 438-444.

Indicio de calidad: 117/261 (Biotecnology & Applied Microbiology). Fi: 2.250, T2, Q2

Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review.

Durks D, Fernandez-Llimos F, Hossain LN, Franco-Trigo L, Benrimoj SI, Sabater-Hernández D.

Health Educ Behav, 2017, Aug; 44(4):524-535

Indicio de calidad: 55/156 (Public Health, Environmental & Occupational Health). Fi: 1.899, T2, Q2

Medication adherence and persistence in type diabetes mellitus: perspectives of patiens, physicians and pharmacists on the Spanish heal care system.

Labrador-Barba E, Rodríguez de Miguel M, Hernández-Mijares A, Alonso-Moreno FJ, Orera-Peña ML, Aceituno S, Faus-Dáder MJ.

Patiens Preference and Adherence, 2017; 11:707-718

Indicio de calidad: 70/155 (Medicine, General & Internal). Fi: 1.733, T2, Q2

Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.

Sanjuan-Cerveró R, Carrera-Hueso FJ, Vazquez-Ferreiro P, Fikri-Benbrahim N, Franco-Ferrando N, Peimer CA.

Journal of Hand Surgery, 2017, 42(2):109-114

Indicio de calidad: 40/77 (Ortopedics). Fi: 1.776, T2, Q3

Modelling elderly patients’ perception of the community pharmacist image when providing professional services.

Sabater-Galindo M, Sabater-Hernández D, Ruiz de Maya S, Gastelurrutia Garralda MA, Martínez-Martínez F, & Benrimoj SI.

Health and Medicine, 2017, 22(5), 578-587.

Indicio de calidad: 107/181 (Public, Environmental & Occupational Health). Fi: 1.589, T2, Q3

Relación entre la satisfacción laboral y la cultura de seguridad del paciente.

Merino-Plaza MJ, Carrera-Hueso FJ, Roca-Castelló MR, Morro-Martín MD, Martínez-Asensi A, Fikri-Benbrahim N.

Gac Sanit, 2017, doi: 10.1016/j.gaceta.2017.02.009

Indicio de calidad: 108/181 (Public Health, Environmental & Occupational Health). Fi: 1,581, T2, Q3

Costan alysisfor the implementation of a medication review with follow-up service in Spain.

Noain A, Garcia-Cardenas V, Gastelurrutia MA, Malet-Larrea A, Martinez-Martinez F, Sabater-Hernandez D, Benrimoj SI.

Int J Clin Pharm, 2017, Aug; 39(4):750-758

Indicio de calidad: 209/261 (Pharmacology & Pharmacy). Fi: 1.508, T3, Q4

Impact of a program me for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial.

Juanes A, Garín N, Mangues MA, Herrera S, Puig M, Faus MJ, Baena MI.

Eur J Hosp Pharm, 2017, 1-7.

Indicio de calidad: 250/261 (Pharmacology & Pharmacy). Fi: 0.538, T3, Q4

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

Maldonado-Montoro M, Cañadas-Garre M, González-Utrilla A, Plaza-Plaza JC, Calleja-Hernández MÁ.

Pharmacol Res, 2016, Jun 20; 111: 264-271.

Fi: 4.816, T, Q1

ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.

Madrid-Paredes A, Cañadas-Garre M, Sánchez-Pozo A, Segura-Pérez AM, Chamorro-Santos C, Vergara-Alcaide E, Castillo-Portellano L, Calleja-Hernández MÁ.

Pharmacol Res, 2016, Apr 30;108: 111-118.

Fi: 4.816, T, Q1

Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Delgado JR, Calleja-Hernández MA, Faus-Dáder MJ.

Pharmacol Res, 2016, Aug 3; 111:877-884.

Fi: 4.816, T, Q1

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

Maldonado-Montoro M, Cañadas-Garre M, González-Utrilla A, Plaza-Plaza JC, Calleja-Hernández MÁ.

Pharmacol Res, 2016, Sep;111: 264-271.

Fi: 4.816, T, Q1

The impact of a Medication Review with Follow-up service on hospital admissions in aged polypharmacy patients.

Malet-Larrea A, Goyenechea E, García-Cárdenas V, Calvo B, Arteche JM, Aranegui P, Zubeldia JJ, Gastelurrutia MA, Martínez-Martínez F, Benrimoj SI.

Br J Clin Pharmacol, 2016, May 14. doi: 10.1111/bcp.13012.

Fi: 3.830, T, Q1

Intraocular lens dislocation in pseudoexfoliation: a systematic review and meta-analysis.

Vazquez-Ferreiro P, Carrera-Hueso FJ, Fikri-Benbrahim N, Barreiro-Rodriguez L, Diaz-Rey M, Ramón-Barrios MA.

Acta Ophthalmol, 2016, 1-6.

Fi: 3.032, T, Q1

A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular diseases.

Sabater-Hernández D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain LN, Durks D, Franco-Trigo L, Lones LA, Correr CJ, Benrimoj SI.

J Manag Care Spec Pharm, 2016, 22 (6): 699-713.

Fi: 2.713, T, Q1

Model for the evaluation of implementation programs and professional pharmacy services.

Moullin JC, Sabater-Hernández D, Benrimoj SI.

Res Social Adm Pharm, 2016, May-Jun; 12(3): 515-22.

Fi: 2.403, T, Q1

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.

Galindo J, Amariles P, Mueses-Marín HF, Hincapié JA, González-Avendaño S, Galindo-Orrego X

BMC Infect Dis, 2016, Oct 3;16(1): 532.

Fi: 2.690, T, Q2

AIntraoperative complications of phacoemulsification in pseudoexfoliation: Metaanalysis.

Vazquez-Ferreiro P, Carrera-Hueso FJ, PoquetJornet JE, Fikri-Benbrahim N, Barreiro-Rodriguez L, Diaz-Rey, M, Ramon Barrios M.

J Cataract Refract Surg, 2016; 42:1666-1675.

Fi: 2.687, T, Q2

Patients’ Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study.

Pagès-Puigdemont N, Mangues MA,Masip M, Gabriele G, Fernández-Maldonado L, Blancafort S, Tuneu L.

Adv Ther , 2016, 33:1740-1754.

Fi: 2.503, T, Q2

Safe implementation of standard concentration infusions in paediatric intensive care.

Safe implementation of standard conceArenas-López S, Stanley IM, Tunstell P, Aguado-Lorenzo V, Philip J, Perkins J, Durward A, Calleja-Hernández MA, Tibby SM.

J Pharm Pharmacol, 2016, Jun 23 doi: 10.1111/jphp.12580.

Fi: 2.363, T, Q2

Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective.

Sabater-Galindo M, Fernández-Llimós F, Sabater-Hernández D, Martínez-Martínez F, Benrimoj SI.

Patient Educ Couns, 2016, Mar; 99(3):339-347.

Fi: 2.199, T, Q2

Free software to analyse the clinical relevance of drug interactions with antiretroviral agents (SIMARVR) in patients with HIV/AIDS.

Giraldo NA, Amariles P, Monsalve M, Faus MJ.

Res Social Adm Pharm. 2016. [23 Sep 2016, 13(4):831-839]

Fi: 1.936, T, Q2

Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting.

Garcia-Cardenas V, Benrimoj SI, Ocampo CC, Goyenechea E, Martinez-Martinez F, Gastelurrutia MA.

Research in Social & Administrative Pharmacy, 2016, doi:10.1016/j.sapharm.2016.05.048.

Fi: 1.860, T, Q2

Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach.

Sabater-Hernández D, Moullin J, Hossain L, Durks D, Franco-Trigo L, Fernandez-Llimos F, Martínez Martínez, Saez-Benito L, De la Sierra A, Benrimoj SI.

Am J Health Syst Pharm, 201,. 73:156-164.

Fi: 1.882, T, Q3

Qualitative study on the implementation of professional pharmacy services in community pharmacy using framework analysis.

Moullin JM, Sabater-Hernández D, Benrimoj SI.

BMC Health Serv Res, 2016, 16: 439. FI: 1.606. Q3

Fi: 1.606, T, Q3

Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmacies.

Amariles P, Pino-Marín D, Sabater-Hernández D, García-Jiménez E, Roig-Sánchez I, Faus MJ.

Aten Primaria, 2016, Nov; 48(9):586-595.

Fi: 1.098, T, Q3

Prevalence and predictors of inadequate patient medication knowledge.

Romero-Sanchez J, Garcia-Cardenas V, Abaurre R, Martínez-Martínez F, Garcia-Delgado P.

J Eval Clin Pract, 2016, Oct; 22(5): 808-815.

Fi: 1.053, T, Q3

Development and testing of two implementation tools to measure components of professional pharmacy service fidelity.

Moullin JM, Sabater-Hernández D, Garcia-Corpas JP, Kenny P, Benrimoj SI.

J Eval Clin Pract, 2016, 22(3): 369-377.

Fi: 1.053, T, Q3

Liquid biopsy in ear lystage lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Robles AI, Molina MA, Faus-Dáder MJ, Calleja-Hernández MA.

Transl Lung Cancer Res, 2016, Oct; 5(5): 517–524.

Fi: 4.806, T, Q4

Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.

Domingues EA, Ferrit Martin M, Calleja Hernandez MA.

Int J Clin Pharm, 2016, DOI 10.1007/s11096-016-0387-1.

Fi: 1.339, T, Q4

Cardiovascular risk in HIV patients aged 50 years and over on antiretroviral therapy: an observational follow-up study.

Domingues EA, Ferrit-Martín M, Calleja-Hernández MA.

Lat Am J Pharm, 2016, 35(Suppl. 1):1083-91

Fi: 0.329, T, Q4

Pharmacists’ interventions on clinical asthma outcomes: a systematic review.

García-Cárdenas V, Armour C, Benrimoj SI, Martínez-Martínez F, Rotta I, Fernández-Llimós.

Eur Respir J, 2015 ,Apr; 47 (4): 1134-43. doi: 10.1183/13993003.01497-2015.

Fi: 8.332, T, Q1

Differences in cancer drug assessment between Spain and the United Kingdom.

Lozano-Blázquez A, Rickson R, Fraga-Fuentes MD, Martínez-Martínez F, Calleja-Hernández MÁ.

Eur J Cancer, 2015, Sep; 51(13):1843-52.

Fi: 5.417, T, Q1

MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Robles AI, Molina MA, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacol Research, 2015, 102: 90-106. FI: 4.408. Q1

Fi: 4.408, T, Q1

Ensayo clínico controlado y aleatorizado para evaluar el efecto que tiene la intervención de un farmacéutico especialista en los problemas relacionados con la medicación de pacientes ancianos ingresados en una unidad de corta estancia de urgencias.

Piqueras Romero C, Calderón Hernanz B, Segura Fragoso A, Juárez González R, Berrocal Javato MA, Calleja Hernández MA.

Emergencias, 2015, 27: 364-370.

Fi: 2.895, T, Q1

Trends in survival of multiple myeloma: a thirty-year population-based study in a single institution.

Ríos-Tamayo R, Sánchez MJ, Puerta JM, Sáinz J, Chang DY, Rodríguez T, López P, de Pablos JM, Navarro P, de Veas JL, Romero A, Garrido P, Moratalla L, Alarcón-Payer C, López-Fernández E, González PA, Jiménez-Moleón JJ, Calleja-Hernández MÁ, Jurado M.

Cancer Epidemiol, 2015, Oct;39(5):693-9.

Fi: 2.644, T, Q1

Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia.

Cortés de Miguel S, Calleja-Hernández MÁ, Menjón-Beltrán S, Vallejo-Rodríguez I.

Support Care Cancer, 2015, Feb; 23(2): 547-59.

Fi: 2.535, T, Q1

Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.

Madrid-Paredes A, Cañadas-Garre M, Sánchez-Pozo A, Calleja-Hernández MÁ.

Breast Cancer Res Treat, 2015, Oct;153(3): 493-505.

Fi: 4.085, T, Q2

PTEN and PI3K/AKT in non small cell lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Robles AI, Molina MA, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacogenomics, 2015, 16(6): 1843-1862.

Fi: 3.218, T, Q2

MET: A New Promising Biomarker in Non-Small Cell Lung Carcinoma.

Pérez-Ramírez C, Cañadas-Garre M, Jiménez-Varo E, Faus-Dáder MJ, Calleja Hernández MA.

Pharmacogenomics, 2015, Apr; 16(6): 631-47.

Fi: 3.218, T, Q2

De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.

Madrid-Paredes A, Cañadas-Garre M, Sánchez-Pozo A, Calleja-Hernández MÁ.

Pharmacogenomics, 2015, 16(12):1411-26.

Fi: 3.218, T, Q2

Extrapolation of acenocoumarol pharmacogenetic algorithms.

Jiménez-Varo E, Cañadas-Garre M, Garcés-Robles V, Gutiérrez-Pimentel MJ, Calleja-Hernández MÁ.

Vascul Pharmacol, 2015, Nov;74:151-7.

Fi: 2.500, T, Q2

Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE Program.

Jódar F, Malet A, Martín JJ, García, L, López del Amo MP, Martínez-Martínez F, Gastelurrutia MA, García-Cárdenas V, Sabater-Hernández, Sáez-Benito L, Benrimoj B.

Pharmacoeconomics, 2015, Jun;33(6): 599-610.

Fi: 2.450, T, Q2

A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework.

Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI.

Health Res Policy Syst, 2015, 13(16): 1-11.

Fi: 1.810, T, Q2

The effect on potential adverse drug events of a pharmacist-acquired medication history in an emergency department: a multicentre, double-blind, randomised, controlled, parallel-group study.

Becerra-Camargo J, Martínez-Martínez F, García-Jiménez E.

BCM Health Services Research, 2015 15:337. DOI 10.1186/s12913-015-0990-1.

Fi: 1.712, T, Q2

Pharmaceutical care in smoking cessation.

Marín Armero A, Calleja MA, Perez-Vicente S, Martinez Martinez F.

Patient Preference and Adherence 2015; 9: 209-2015.

Fi: 1.676, T, Q2

Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments.

Pérez-Escamilla, B., Franco-Trigo, L., Moullin, J.C., Martínez-Martínez, F., García-Corpas, J.P.

Patient Prefer Adherence, 2015, 13; 9 569–578.

Fi: 1.676, T, Q2

Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study. [Original].

Fikri-Benbrahim N, Martinez-Martinez F, Sáez-Benito L, Luque BS, Corpas JP, Moullin JC et al.

Diabetes Research and Clinical Practice, 2015, 108(3): 49-52.

Fi: 2.538, T, Q3

Negative outcomes associated with medication in patients with chronic atrial fibrillation who present at the emergency department.

Torres-Degayón V, Torres-Murillo JM, Baena-Parejo MI, Muñoz-Villanueva MC, Montes- Redondo G, Calleja-Hernández MA, Faus-Dáder MJ.

Journal of Clinical Pharmacy and Therapeutics, 2015, 40: 452-60.

Fi: 1.668, T, Q3

Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes.

Castrillón Ocampo c, Garcia-Cardenas V, Martinez-Martinez F, Benrimoj SI, Amariles P, Gastelurrutia MA.

Int J Clin Pharm, 2015 Oct;37(5):931-40.

Fi: 1.348, T, Q3

Caracterization of patients´ requests and pharmacists´ professional practice in oropharyngeal condition in Spain.

Hernández A, García-Delgado P, García-Cardenas V, Ocaña A, Labrador E, Orera ML.

Int J Clin Pharm, 2015, 37(2): 300-9.

Fi: 1.348, T, Q3

Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.

Masip M, Tuneu L, Pagès N, Torras X, Gallego A, Guardiola JM, Faus MJ, Mangues MA.

Int J Clin Pharm, 2015, Dec; 37 (6): 1143-51Epud 2015. DOI 10.1007/s11096-015-0177-1.

Fi: 1.348, T, Q3

Development and testing of two implementation tools to measure components of professional pharmacy service fidelity.

Moullin JC, Sabater-Hernández, García-Corpas JP, Kenny P, Benrimoj SI.

J Eval Clin Pract, 2015, Dec 29.doi: 10.1111/jep.12496.

Fi: 1.084, T, Q3

Medication List Assessment in Spanish Hospital Emergency Departments.

Medication List AssBaena Parejo MI, Juanes Borrego AM, Altimiras Ruiz J, Crespí Monjó M, García-Peláez M, Calderón Hernanz B, Calleja Hernández MÁ, Chinchilla Fernández MI, Prats Riera M, García Sánchez R, García Sánchez L, Vázquez López C, Mauleon Echeverria MD, Mas Serrano P. J

Emerg Med, 2015, Apr;48(4):416-23.

Fi: 0.969, T, Q3

Diseño y pilotaje de un proceso estructurado para el servicio de dispensación de medicamentos.

Abaurre R, García-Delgado P, Maurandi MD, Arrebola C, Gastelurrutia MA, Martínez-Martínez F.

Aten Primaria, 2015, 17(1): 7 – 14.

Fi: 0.953, T, Q3

Pharmacist perception of the use of analgesics and their practice on mild-moderate pain. DOLOR-OFF survey

Arrebola C, García-Delgado P, Labrador Barba E, Orera Peña ML, Martínez-Martínez F.

Aten Primaria, 2015, Oct 28.

Fi: 0.953, T, Q3

Identifying masked uncontrolled hypertension in the community pharmacy setting.

Sabater-Hernández D, Sendra-Lillo J, Jiménez-Monleón JJ, Benrimoj S, Durks D, Martínez-Martínez F, de la Sierra A.

Blood Press Monit, 2015, 20(3): 138-43.

Fi: 1.531, T, Q4

Validity of home blood pressure measurements manually registered by patients after an educational session provided by community pharmacists.

Sendra-Lillo J, Martínez-Martínez , García-Corpas JP, Marín Rivas F, Sabater-Hernández D.

Blood Press Monit, 2015, 20(4):232-6.

Fi: 1.531, T, Q4

Atención Farmacéutica en el Fomento del Desayuno Saludable desde la Oficina de Farmacia.

Marín Rives F, Morales Marin F, Marín Rives LV, Gastelurrutia Garralda MA.

Nutr Hosp, 2015, 32 (03): 1267-1272.

Fi: 1.497, T, Q4

Use of pemetrexed for non-small celllung cancer in theAndalusian public health system.

Pérez-Moreno MA, Cotrina-Luque J, Galván-Banqueri M, Flores-Moreno S, Bautista-Paloma FJ, Calleja-Hernández MÁ.

J Chemother, 2015, 27(6): 371-7.

Fi: 1.333, T, Q4

Usefulness of blood pressure measurements by community pharmacists in screening for hypertension the screenBpharm study: a protocol.

Marín-Rives FR, Sendra-Lillo J, Morales F, Sabater-Hernández D.

Lat Am J Pharm, 2015, 34(2): 237-243.

Fi: 0.372, T, Q4

Adherence to Antihypertensive Therapy in Community Pharmacy: Evaluating the Psychometric Properties of the Morisky Medication Adherence Scale (MMAS-8) Translated into Spanish. Pilot Study.

Pareja-Martínez E, Esquivel-Prados E, Franco-Trigo L, García-Corpas JP.

Lat Am J Pham. 2014; 33(5):739-45.

Fi: 0.319, T, Q4

Pharmacogenetics role in the safety of acenocoumarol therapy.

Jiménez-Varo E, Cañadas-Garre M, Henriques CI, Pinheiro AM, Gutiérrez-Pimentel MJ, Calleja-Hernández MA.

Thromb Haemost, 2014, Sep 2;112(3):522-36.

Fi: 4.984, T, Q1

Implementing smart pump technology in a pediatric intensive care unit: a cost-effective approach.

Manrique-Rodríguez S, Sánchez-Galindo AC, López-Herce J, Calleja-Hernández MA, Martínez Martínez F, Iglesias- Peinado I, Carrillo-Álvarez A, Sanjurjo-Sáez M, Fernández-Llamazares CM.

Int J Med Inform, 2014, Feb;83(2): 99-105.

Fi: 2.004, T, Q1

Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study).

Losada-Camacho M, Guerrero-Pabón MF, García-Delgado P y Martínez-Martínez F.

Health Qual Life Outcomes, 2014, Oct 31; 12(1):162.

Fi: 2.120, T, Q2

Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: study protocol for a randomized controlled trial.

Salazar-Ospina A, Amariles P, Benjumea DM, Gutierrez F, Faus MJ, Rodriguez LF.

Trials, 2014, May 20;15:174. doi: 10.1186/1745-6215-15-174.

Fi: 1.731, T, Q3

Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice.

Lozano-Blázquez A, Calvo-Pita C, Carbajales-Álvarez M, Suárez-Gil P, Martínez-Martínez F, Calleja-Hernández MA.

Therapeutics and Clinical Risk Management, 2014, 10: 527–535.

Fi: 1.469, T, Q3

Characterization of patients’ requests and pharmacists’ professional practice concerning the oropharyngeal condition in Spain.

Hernández A, García-Delgado P, García-Cárdenas V, Ocaña A, Labrador E, Orera ML, Martínez-Martínez F.

International Journal of clinical pharmacy, 2015, 37; 2: 300-309.

Fi: 1.348, T, Q3

The effect of an educational intervention to improve patient antibiotic adherence during dispensing in a community pharmacy.

Bernabé E, Martínez F, Espejo J, Flores M.

Aten Primaria, 2014, 46(7): 367-375.

Fi: 0.953, T, Q3

Comparación de las intervenciones de educación sanitaria y de seguimiento farmacoterapéutico en pacientes con factores de riesgo cardiovascular que acuden a una farmacia comunitaria (Estudio FISFTES-PM).

Bofí Martínez P, García-Jiménez E.

Aten Primaria, 2014, http://dx.doi.org/10.1016/j.aprim.2014.04.012.

Fi: 0.953, T, Q3

Grado de conocimiento del antibiótico prescrito en pacientes ambulatorios.

Bernabé Muñoz E, Flores Dorado M, Martínez-Martínez F.

Aten Primaria, 2014, DOI: 10.1016/J.APRIM.2014.04.014.

Fi: 0.953, T, Q3

Validación del cuestionario de medida del conocimiento del paciente sobre su medicamento adaptado al portugués.

Salmerón-Rubio J, García-Delgado P, Iglésias-Ferreira P, Mateus-Santos H, Martínez-Martínez F.

Ciência & Saúde Coletiva, 2014, 19(4): 1141-1150. 18(12):3633-3644.

Fi: 0.56, T, Q4

Lifestyles habits and sleeps quality in patients over age of 65 attending community pharmacies.

García-Corpas JP, Sabater-Hernández D, Martínez-Martínez F.

Lat Am J Pham, 2014, 33(5):739-45.

Fi: 0.319, T, Q4

Relationship between urinary albumin excretion and blood pressure in the community pharmacy. The Palmera study.

Sendra-Lillo J, Sabater-Hernández D, de la Sierra A, Sendra-Ortolá A, Denia-Tomás A, Martínez-Martínez F.

Am J Hypertens, 2013, 26(1): 3-4.

Fi: 3.402, T, Q2

Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients.

Sáez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI.

Age Ageing, 2013, 42(4): 442-449.

Fi: 3.107, T, Q2

Effect of a pharmacist intervention on asthma control. A cluster randomised trial.

García-Cárdenas V, Sabater-Hernández D, Kenny P, Martínez-Martínez F, Faus MJ, Benrimoj SI.

Respir Med, 2013, Sep;107(9): 1346-55.

Fi: 2.917, T, Q2

Negative clinical outcomes of medication resulting in emergency department visits.

Baena MI, Fajardo PC, Pintor-Marmol A, Faus MJ, Marin R, Zarzuelo A.et al.

Eur J Clin Pharmacol, 2013, 70(1): 79-87.

Fi: 2.697, T, Q2

Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Salgado TM, Arguello B, Martinez-Martinez F, Benrimoj SI, Fernandez-LlimosF.

Eur J Clin Pharmacol, 2013, 69(11): 1973-9.

Fi: 2.697, T, Q2

Comparison of drug survival rates for tumor necrosis factor antagonists in reumatoide artritis.

Martínez-Santana V, González-Sarmiento E, Calleja-Hernández M, Sánchez-Sánchez T.

Patient Prefer Adherente, 2013, Jul 29; 7:719-27.

Fi: 1.330, T, Q2

Impact of implementing smart infusion pumps in a pediatric intensive care unit.

Manrique-Rodríguez S, Sánchez-Galindo A, López-Herce J, Calleja-Hernández MA, Martínez-Martínez F, Iglesias-Peinado I, Carrillo-Álvarez Á, Sanjurjo-Sáez M, Fernández-Llamazares CM.

Am J Health Syst Pharm, 2013, 70 (21): 1897-906.

Fi: 2.205, T, Q3

A multicentre, double-blind, randomised, controlled, parallel-group study of the effectiveness of a pharmacist-acquired medication history in an emergency department.

Becerra Camargo JB, Martinez F, García-Jiménez E.

BMC Health Serv Res, 2013, Aug 29; 13(1): 337.

Fi: 1.659, T, Q3

Impact of a community pharmacists’ hypertension-care service on medication adherence. The AFenPA Study.

Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D.

Res Social Adm Pharm, 2013, 9(6): 797-805.

Fi: 1.375, T, Q3

Reply to the paper: Defining professional pharmacy services in community pharmacy.

Gastelurrutia MA, Faus MJ, Martínez-Martínez F.

Research in Social and Administrative Pharmacy, 2013, DOI: 10.1016/j.sapharm.2013.05.005

Fi: 1.375, T, Q3

Drug-related visits to the emergency department in Spanish university hospital.

Castro I, Guardiola JM, Tuneu L, Sala ML, Faus MJ, Mangues MA.

Drug-related visits to the emergency department in Spanish university hospital. Castro I, Guardiola JM, Tuneu L, Sala ML, Faus MJ, Mangues MA. Int J Clin Pharm. 2013; 35: 727-735.

Fi: 1.250, T, Q3

Effectiveness and safety of doxorubicinloadedbeads in hepatocellular carcinoma.

Muros-Ortega M, Díaz-Carrasco MS, Capel A, Calleja MÁ, Martínez F.

Int J ClinPharm, 2013, 35(6): 1105-12.

Fi: 1.250, T, Q3

Revisión de la medicación de pacientes polimedicados en atención primaria.

Flores M, Baena MI, Jiménez J, Tormo J, Faus MJ, Martínez F.

Aten Primaria, 2013, 45(4): 222-3.

Fi: 0.894, T, Q3

Priorización de facilitadores para la implantación del seguimiento farmacoterapéutico en las farmacias comunitarias españolas mediante la aplicación de análisis factorial exploratorio.

Gil MI, Benrimoj SI, Martínez-Martínez F, Cardero M, Gastelurrutia MA.

Aten Primaria, 2013, 45(7): 368-375.

Fi: 0.894, T, Q3

Programa conSIGUE Impacto. Evaluación del impacto clínico, económico y humanístico del seguimiento farmacoterapéutico en adultos mayores polimedicados.

Martínez-Martínez F, García-Cárdenas V, Sáez-Benito L, Varas R, Gastelurrutia MA, Sabater-Hernández D, Faus MJ, Benrimoj SI.

Vitae, 2013, 20 (supl. 1): S15-S18.

Fi: 0.259, T, Q3

Prevalence and Attitude Towards Smoking in First, Third and Fifth-year Pharmacy Students in Spain: PRECOTABAC Study.

Muñoz Muñoz E, García-Jiménez E, Martínez-Martínez F, Espejo Guerrero J.

Therapie, 2013, 68(6): 375-383.

Fi: 0.397, T, Q4

Diseño de un paciente virtual para el entrenamiento y práctica de la Atención Farmacéutica.

Martínez-Martínez F, García-Cárdenas V, Fikri-Benbrahim N, García-Delgado P, Faus MJ.

Vitae, 2013, (Supl 1): S52-S53.

Fi: 0.325, T, Q4

Effectiveness of Pharmacotherapy Follow-Up for the Control of Hypertensive Patients in Community Pharmacies: EMDADER-HTA Study.

Rodríguez-Chamorro A, García-Jiménez E, Rodríguez-Chamorro MA, Amariles P, Martínez-Martínez F, Pérez-Merino E, González-García l, Faus-Dader MJ.

Latin Am J Pharm, 2013, 32 (7): 982-988.

Fi: 0.319, T, Q4

Effect of Pharmacotherapy Follow-Up on Treatment Adherence and Virologic and Immune Response in Patients with Human Immunodeficiency Virus.

Romero Jiménez R, Calleja Hernández MA, Chaparro Recio M, Martínez-Martínez F, Sanjurjo Sáez M.

Latin American Journal of Pharmacy, 2013, 32 (3): 441-447.

Fi: 0.319, T, Q4

Prevalencia y Factores asociados al insomnio y mala calidad de sueño en pacientes con VIH/SIDA en Sevilla, España.

García-Corpas JP, Monje-Agudo P, Labriola C, Morillo-Verdugo R.

Vitae, 2013, 20(3): 195-202.

Fi: 0.259, T, Q4

Análisis de la dispensación de antibióticos en pacientes ambulatorios.

Bernabé Muñoz E, Flores Dorado M, Martinez-Martinez F.

Vitae, 2013, 20 (3): 2013-2014.

Fi: 0.259, T, Q4

Adaptação intercultural para português europeu do questionário “Conocimiento del Paciente sobre sus Medicamentos” (CPM-ES-ES).

Salmerón-Rubio J, Iglésias-Ferreira P, García-Delgado P, Mateus-Santos H, Martínez-Martínez F.

Ciência & Saúde Coletiva, 2013, 18(12):3633-3644.

Fi: 0,56, T, Q4

Agreement between community pharmacy, physician’s office and home blood pressure measurement methods. The PALMERA study.

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá A, Martínez-Martínez F.

Am J Hypertens. 2012; 25 (3): 290-296.

Fi: 3.665, T, Q1

The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation

Calleja MA, Vieites JM, Montero-Meterdez T, Torres MI, Faus MJ, Gil MA, Suárez A.

British Journal of Nutrition. 2012: 1-18.

Fi: 3.302, T, Q1

Impact of clinical pharmacist interventions in reducing paediatric prescribing errors.

Fernández-Llamazares C, Calleja MA, Manrique-Rodriguez S, Pérez- Sánz C, Durán-García E, Sanjurjo-Saéz M.

Arch Dis Child. 2012; 97: 564–568.

Fi: 3.051, T, Q1

Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.

Amariles P, Sabater-Hernández D, García-Jiménez E, Rodríguez-Chamorro MÁ, Prats-Más R, Marín-Magán F, Galán-Ceballos JA, Jiménez-Martín J, Faus MJ.

J Manage Care Pharm. May; 18(4):311-23.

Fi: 2.414, T, Q1

Usefulness of Blood Pressure Measurement by Community Pharmacists in the Management of Hypertension.

Sabater-Hernández D, Sendra-Lillo J, Faus MJ, Martínez-Martínez F, de la Sierra A.

Journal of Managed Care Pharmacy. July/August 2012; 18: (6): 453-456.

Fi: 2.414, T, Q1

Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain. European Journal of Clinical Pharmacology.

Fernández-Llamazares C, Calleja MA, Manrique-Rodriguez S , Pérez- Sánz C, Durán-García E, Sanjurjo-Saéz M.

Eur J Clin Pharmacol 2012; 68(9):1339-45.

Fi: 2.741, T, Q2

MEPAFAR Study Workgroup. Agreement between community pharmacy and ambulatory and blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study.

Sabater-Hernández D, De La Sierra A, Sánchez-Villegas P, Santana-Pérez FM, Merino-Barber L, Faus MJ.

J Clin Hypertens. 2012; 14(4): 236-244.

Fi: 2.364, T, Q3

Validation of a method for recording pharmaceutical interventions.

Fernández-Llamazares CM, Manrique-Rodríguez S, Pérez-Sanz C, Durán-García ME, Sanjurjo-Sáez M, Calleja-Hernández MA.

J Clin Pharm Ther. 2012 Aug;37(4):459-63.

Fi: 2.104, T, Q3

Severe pancy to penia following etanercept administration in rheumatoid arthritis.

Martínez Santana V, Izquierdo Navarro M, Calleja Hernández MA, Sánchez Sánchez T, Sainz Gil, M.

International Journal of Rheumatic Diseases 2012; 15(4): e78–e79.

Fi: 1.469, T, Q3

Estudio piloto sobre el manejo de la fluidoterapia intravenosa en pacientes adultos de un hospital de tercer nivel.

Cordero Cruz AM, Moreno Villares JM, Gomis Muñoz P, Valero Zanuy MA, Calleja Hernández MA.

Nutr Hosp. 2012; 27(3): 943-947.

Fi: 1.305, T, Q4

Pharmaceutical care for patients undergoing assisted reproduction techniques. European Journal of Hospital Pharmacy.

Heredia M, Tenías JM, Ruiz R, Sánchez M, CallejaMA, Martínez F.

Eur J Hosp Pharm 2012; 19: 289-292.

Fi: 0.433, T, Q4

Investigar y publicar en Atención Farmacéutica: una labor por fortalecer.

Amariles P, Sabater-Hernández D, Faus MJ.

Vitae. 2012; 19(1): 9-11.

Fi: 0.325, T, Q4

Validation of a Methodology for Inpatient Pharmacotherapy follow-up.

Becerra J, Martínez F, Bohorquez M, L. Guevara M, Ramirez N E.

Vitae, 2012; 19, 3: 261-269.

Fi: 0.325, T, Q4

Intensive Two-Month Intervention on Diet and Lifestyle in Uncontrolled Hypertensive Patients in a Community Pharmacy.

Zaragoza-Fernández MP, Gastelurrutia MA, Cardero M, Martínez-Martínez M.

Lat Am J Pharm. 2012; 31 (5): 727-733.

Fi: 0.244, T, Q4

Adecuación de la profilaxis antimicrobiana perioperatoria en apendicitis.

Colmenares ME, Labastida C, Aznarte Padial P, Calleja Hernández MA, Martínez Martínez F.

Aten Farm 2012; 14(4): 245-250.

Fi: 0.125, T, Q4

Controversies in the management of adjuvant breast cancer with taxanes: review of the current literature

Araque Arroyo P, Ubago Pérez R, Cancela Díez B, Fernández Feijóo MA, Hernández Magdalena J, Calleja Hernández MA.

Cancer Treat Rev. 2011 Apr; 37(2): 105-110

Fi: 6.024, T, Q1

Obesity paradox and risk of sudden death in heart failure

Gastelurrutia P, Pascual-Figal D, Vazquez R, Cygankiewicz I, Grigorian-Shamagian L, Puig T, el al.

Am Heart J. 2011; 161(1): 158-164

Fi: 4.651, T, Q1

Relationship between kidney damage and blood pressure measurements in the community pharmacy, at home and the physicians office. The Palmera study

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortola A, Martínez-Martínez F.

Am J Hypertens. 2011; 29 (e-Suppl.A): e-313

Fi: 3.181, T, Q1

Agreement between community pharmacy physicians office and home blood pressure measurement methods. The Palmera study

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortola A, Martínez-Martínez F.

Am J Hypertens. 2011; 25(3): 290-296

Fi: 3.181, T, Q1

Magnitude of the white-coat effect in the community pharmacy setting. The MEPAFAR study

Sabater-Hernández D, de la Sierra A, Sánchez-Villegas P, Baena MI, Amariles P, Faus MJ.

Am J Hypertens. 2011; 24(8): 887-892

Fi: 3.181, T, Q1

Negative clinical outcomes associated with drug-related problems in heart failure (HF) out patiens: impact of a pharmacist in a multidisciplinary HF clinic

Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues A, Bayes-Genis A.

J Card Fail. 2011; 17(3): 217-223

Fi: 3.660, T, Q2

Comparison of the white-coat effect in the community pharmacy versus the physian office. The PALMERA study

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortola A, Martínez-Martínez F.

Blood Press Monit. 2011; 16(2): 62-66

Fi: 1.520, T, Q3

Evaluation of the hypertensive state in treated patients: selection of appropriate blood pressure measurements per visit to community pharmacy

Sabater-Hernández D, Sánchez-Villegas P, Lacampa P, Artiles-Campelo A, Jorge-Rodriguez ME, Faus MJ.

Blood Press Monit. 2011; 16(3): 103-110.

Fi: 1.520, T, Q3

Efecto de la actuación farmacéutica en la adherencia del tratamiento farmacológico de pacientes ambulatorios con riesgo cardiovascular (Estudio EMDADER-CV-INCUMPLIMIENTO)

Rodríguez Chamorro MÁ, García-Jiménez E, Amariles P, Rodríguez Chamorro A, Pérez Merino E, Martínez Martínez F y Faus Dader MJ.

Aten Primaria. 2011; 43(5): 245-253

Fi: 0.627, T, Q3

Analysis of the effects of pharmacotherapeutic follow-up in hypothyroid patients seen in community pharmacy

Bofí Martínez P, García-Jiménez E, Martínez- Martínez F.

Aten Primaria. 2011 Jan; 43(1):50-52

Fi: 0.627, T, Q3

Effect of pharmacist involvement in adherence to medications in patients with high to moderate cardiovascular risk (Study EMDADER-CV-INCUMPLIMIENTO)

Rodríguez Chamorro MA, García-Jiménez E, Amariles P, Chamorro AR, Merino EM, Martínez FM, Dader MJ.

Aten Primaria. 2011 May; 43(5): 245-253

Fi: 0.627, T, Q3

Bioelectrical impedance vector analysis (BIVA) in stable and non-stable heart failure patients: a pilot study

Gastelurrutia P, Nescolarde L, Rosell-Ferrer J, Domingo M, Ribas N, Bayes-Genis A.

Int J Cardiol. 2011; 146(2): 262-264

Fi: 1.185, T, Q4

Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study

Sabater-Hernández D, Sánchez-Villegas P, Amariles P, García-Corpas JP, Sendra-Lillo J, Faus MJ.

Int J Clin Pharm. 2011; 33(3): 582-589.

Fi: 0.859, T, Q4

Control de errores por alergias cruzadas a antibióticos betalactámicos

Sánchez IM, Nájera MD, Calleja MA, Belchi J.

Aten Farm 2011; 13(2): 121-123

Fi: 0.082, T, Q4

Investigación en Atención Farmacéutica: una necesidad con ciertos requisitos

Amariles P, Faus MJ.

Aten Farm. 2011; 13(1): 3-5

Fi: 0.082, T, Q4